[{"orgOrder":0,"company":"ARTHEx Biotech","sponsor":"EIC Accelerator","pharmaFlowCategory":"D","therapeuticArea":"Genetic Disease","country":"SPAIN","productType":"Large molecule","year":"2022","type":"Funding","leadProduct":"ATX-01","moa":"MBNL protein","graph1":"Genetic Disease","graph2":"IND Enabling","graph3":"ARTHEx Biotech","amount2":0.01,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Genetic Disease","amount2New":0.01,"dosageForm":"","sponsorNew":"ARTHEx Biotech \/ EIC Accelerator","highestDevelopmentStatusID":"5","companyTruncated":"ARTHEx Biotech \/ EIC Accelerator"},{"orgOrder":0,"company":"ARTHEx Biotech","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"SPAIN","productType":"Large molecule","year":"2022","type":"Not Applicable","leadProduct":"ATX-01","moa":"","graph1":"Genetic Disease","graph2":"IND Enabling","graph3":"ARTHEx Biotech","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"","sponsorNew":"ARTHEx Biotech \/ Not Applicable","highestDevelopmentStatusID":"5","companyTruncated":"ARTHEx Biotech \/ Not Applicable"},{"orgOrder":0,"company":"ARTHEx Biotech","sponsor":"Columbus Venture Partners","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"SPAIN","productType":"Large molecule","year":"2023","type":"Series B Financing","leadProduct":"ATX-01","moa":"","graph1":"Genetic Disease","graph2":"IND Enabling","graph3":"ARTHEx Biotech","amount2":0.050000000000000003,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Genetic Disease","amount2New":0.050000000000000003,"dosageForm":"","sponsorNew":"ARTHEx Biotech \/ Columbus Venture Partners","highestDevelopmentStatusID":"5","companyTruncated":"ARTHEx Biotech \/ Columbus Venture Partners"},{"orgOrder":0,"company":"ARTHEx Biotech","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"SPAIN","productType":"Large molecule","year":"2024","type":"Not Applicable","leadProduct":"ATX-01","moa":"","graph1":"Genetic Disease","graph2":"IND Enabling","graph3":"ARTHEx Biotech","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"","sponsorNew":"ARTHEx Biotech \/ Not Applicable","highestDevelopmentStatusID":"5","companyTruncated":"ARTHEx Biotech \/ Not Applicable"},{"orgOrder":0,"company":"ARTHEx Biotech","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"SPAIN","productType":"Large molecule","year":"2024","type":"Not Applicable","leadProduct":"ATX-01","moa":"","graph1":"Technology","graph2":"Approved","graph3":"ARTHEx Biotech","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Technology","amount2New":0.10000000000000001,"dosageForm":"","sponsorNew":"ARTHEx Biotech \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"ARTHEx Biotech \/ Not Applicable"},{"orgOrder":0,"company":"ARTHEx Biotech","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"SPAIN","productType":"Large molecule","year":"2024","type":"Not Applicable","leadProduct":"ATX-01","moa":"","graph1":"Technology","graph2":"Approved","graph3":"ARTHEx Biotech","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Technology","amount2New":0.10000000000000001,"dosageForm":"","sponsorNew":"ARTHEx Biotech \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"ARTHEx Biotech \/ Not Applicable"}]